Ember
Senior Member
- Messages
- 2,115
Progress reports don't need to be delivered in person.The monthly meetings between IOM and NIH are administrative only.
Last edited:
Progress reports don't need to be delivered in person.The monthly meetings between IOM and NIH are administrative only.
Does anyone know if there is an accessible Public Access File on their website yet?So any material about the substantive work of the study coming from NIH or CDC or AHRQ or Nancy Lee, etc. must go into the Public Access File.
Thanks for that info, Jennie.FACA and IOM policy dictate that any substantive contact about the topic of the study and panel deliberations between IOM and the HHS must be public. MUST BE PUBLIC. So any material about the substantive work of the study coming from NIH or CDC or AHRQ or Nancy Lee, etc. must go into the Public Access File. If they break this rule, HHS cannot use the study report - by law.
Yes, Dr Clayton was very firm and absolute in her statements about contact between the IoM committee and the government. She is chairing the project, so I assume that it's her job to make sure that the committee stays within the law.I was surprised/pleased about how strong Dr. Clayton was in addressing this issue.
...
Dr. Clayton is pretty focused on making sure IOM complies with the policies.
Progress reports don't need to be delivered in person.
Is there a stipulation that these reports will be delivered in person? (There may well be and I missed it --.)Progress reports don't need to be delivered in person.
There is also the issue that some IoM panel members also serve on the P2P workshop panel. In waht way does this make sense?
Do you mean that you see a conflict of interest there, Nielk?There is also the issue that some IoM panel members also serve on the P2P workshop panel. In waht way does this make sense?
One possibility is that there are so few experts for this illness (and even fewer who can take the time from their practices to participate in these projects) that they couldn't help but have some overlap....
Apparently, the reports require monthly meetings:Is there a stipulation that these reports will be delivered in person? (There may well be and I missed it --.)
There is a link with what IoM & P2P committee is doing. We hope to be working together with the IoM committee...no doubt there is a need to share that synergy.
You are kidding...right?
Apparently, the reports require monthly meetings:
meeting
noun
: a gathering of people for a particular purpose (such as to talk about business)
: a gathering of people for religious worship
: a situation or occasion when two people see and talk to each other
re·port
noun
: a story in a newspaper or on radio or television that is about something that happened or that gives information about something
: a written or spoken description of a situation, event, etc.
: an official document that gives information about a particular subject
Progress reports don't require meetings or teleconferences to be delivered.The term meeting is also used for teleconferences. Perhaps that is what they mean.
Statement of Work:My takeaway from watching the discussions around this question was a) Lee/Unger/Maier have not actually thought through what coordinating for synergy means in light of these restrictions....
Also the committee should communicate and coordinate with the Office of Disease Prevention at NIH regarding their ongoing Evidence-based Methodology Workshop for ME/CFS in an effort to minimize overlap and maximize synergy. The coordination with NIH should assure that relevant information is shared and that key messages are coordinated.
HHS has requested that the IOM committee coordinate with two ongoing HHS efforts concerning ME/CFS in order to minimize overlap and maximize synergy. You will be hearing more details from Drs. Unger and Maier today.
Jennie,
Can you explain then, the purpose of NIH's Susan Mayer's lengthy discourse of the entire process of the P2P to the IoM panel?
Are you saying you object to Klimas's involvement on one or both committees? I think a better question is whether the overlapping members have received clear instructions about how to manage these two separate workstreams appropriately without compromising either one. From Klimas's comments on Monday, as of then she had not received clear instructions.There is also the issue that some IoM panel members also serve on the P2P workshop panel. In waht way does this make sense?
How could I possibly do that? That's a question better directed to IOM or Dr. Maier. One possibility that leaps to mind, though, is "we want to make sure it looks like we're doing lots of stuff and we know what we're doing." Or from IOM's perspective, "the Statement of Task requires us to coordinate and that can only happen publicly so here ya go." Speculation on my part, though.
Are you saying you object to Klimas's involvement on one or both committees? I think a better question is whether the overlapping members have received clear instructions about how to manage these two separate workstreams appropriately without compromising either one. From Klimas's comments on Monday, as of then she had not received clear instructions.
That makes sense as part of the HHS effort "to minimize overlap and maximize synergy...[assuring] that relevant information is shared and that key messages are coordinated." Although Dr. Maier redirected Dr. Klimas' request for permission to share a P2P Working Group document with the IOM Committee, Dr. Klimas cannot fail to share information with herself. Two members serving on the IOM consensus committee find themselves in that position.There is also the issue that some IoM panel members also serve on the P2P workshop panel. In waht way does this make sense?